Beacon Capital Management Inc (Ohio)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100	Closed	-$8K	–	111
2016 Q2	$8K	Hold	100	–	–	﹤0.01%	91
2016 Q1	$8K	Hold	100	–	–	﹤0.01%	114
2015 Q4	$10K	Hold	100	–	–	﹤0.01%	124
2015 Q3	$11K	Hold	100	–	–	﹤0.01%	120
2015 Q2	$14K	Hold	100	–	–	﹤0.01%	121
2015 Q1	$12K	Hold	100	–	–	﹤0.01%	134
2014 Q4	$9K	Hold	100	–	–	﹤0.01%	141
2014 Q3	$7K	Hold	100	–	–	﹤0.01%	158
2014 Q2	$6K	Hold	100	–	–	﹤0.01%	170
2014 Q1	$7K	Hold	100	–	–	﹤0.01%	159
2013 Q4	$7K	Buy	+100	New	+$6.79K	﹤0.01%	156

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s BMRN Position: Q3 2016 in Review

Beacon Capital Management Inc (Ohio) sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2016, closing a stake of 100 shares — an estimated $8K sold.

Beacon Capital Management Inc (Ohio) first reported a position in BMRN in Q4 2013 and held it in 11 quarters. The position peaked at $14K in Q2 2015. 422 funds tracked by Wall St. Rank hold BMRN as of Q3 2016.

Beacon Capital Management Inc (Ohio) reported no remaining BioMarin Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Beacon Capital Management Inc (Ohio) sold 100 BioMarin Pharmaceuticals shares in Q3 2016, an estimated $8K.
Beacon Capital Management Inc (Ohio) first reported a position in BioMarin Pharmaceuticals in Q4 2013 and held it in 11 quarters.
Beacon Capital Management Inc (Ohio)'s BioMarin Pharmaceuticals position peaked at $14K in Q2 2015.
422 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2016.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q3 2016, filed 11 Oct 2016.